BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Sterigenics Scoops Up Toxikon’s European Laboratory Biz for Undisclosed Sum

  This acquisition provides a more comprehensive service offering and a platform for growth for Sterigenics’ Nelson Labs business.

  October 31, 2017

   · 

  4 min read
• Business

  Navidea Biopharmaceuticals Schedules Third Quarter 2017 Earnings Conference Call and Business Update

  Navidea announced it will host a conference call on Wednesday, November 8, 2017 at 8:30am E.T. to discuss its financial results for the third quarter 2017, in conjunction with the filing of its quarterly report on Form 10-Q for the third quarter ended September 30, 2017.

  October 31, 2017

   · 

  2 min read
• Business

  Nektar to Announce Financial Results for the Third Quarter of 2017 on Tuesday, November 7, 2017, After Close of U.S.Based Financial Markets

  Nektar Therapeutics will announce its financial results for the third quarter ended September 30, 2017, on Tuesday, November 7, 2017, after the close of U.S.based financial markets.

  October 31, 2017

   · 

  1 min read
• Business

  Medicure Acquires License to Sell and Market PREXXARTAN in the U.S. From Carmel Biosciences

  Under terms of the agreement, Medicure obtains exclusive rights in the United States and territories to develop, manufacture and market PREXXARTAN for a seven year term, with potential extensions to the term available.

  October 31, 2017

   · 

  2 min read
• Business

  Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy

  Kedrion Biopharma will initially distribute INTERCEPT for platelets and plasma and will have the right to distribute INTERCEPT red blood cells following CE mark approval.

  October 31, 2017

   · 

  5 min read
• 

  Biotech Bay

  Bay Area’s VitalConnect Banks $38M Series C

  The round was led by MVM and Baxter Ventures.

  October 31, 2017

   · 

  2 min read
• Bio NC

  Ribometrix Raises $7.5 Million in Seed Funding to Advance Platform for Discovering and Developing Small Molecule Modulators of RNA to Treat Human Diseases

  The investment was led by SV Health Investors and Hatteras Venture Partners.

  October 31, 2017

   · 

  1 min read
• Policy

  Ivantis Completes Pre-Market Approval Submission for the Hydrus Microstent for Minimally Invasive Glaucoma Surgery

  Ivantis announced today that it has submitted its final Pre-Market-Approval module to the FDA for market approval.

  October 31, 2017

   · 

  3 min read
• 

  Biotech Bay

  Here Are the Top 10 In Vitro Diagnostic Companies

  The companies are ranked by revenues of clinical diagnostic test instruments, reagents and supplies.

  October 31, 2017

   · 

  2 min read
• Business

  Kogenix Licenses Gene Therapy for Prevention of Age-Related Dementia and Alzheimer’s

  Boston-based Kogenix licensed the patent-pending technology used in the research.

  October 31, 2017

   · 

  2 min read